Form confers function: Case of the 3'X region of the hepatitis C virus genome
- PMID: 30122877
- PMCID: PMC6092582
- DOI: 10.3748/wjg.v24.i30.3374
Form confers function: Case of the 3'X region of the hepatitis C virus genome
Abstract
At the 3' end of genomic hepatitis C virus (HCV) RNA there is a highly conserved untranslated region, the 3'X-tail, which forms part of the 3'UTR. This region plays key functions in regulation of critical processes of the viral life cycle. The 3'X region is essential for viral replication and infectivity. It is also responsible for regulation of switching between translation and transcription of the viral RNA. There is some evidence indicating the contribution of the 3'X region to the translation efficiency of the viral polyprotein and to the encapsidation process. Several different secondary structure models of the 3'X region, based on computer predictions and experimental structure probing, have been proposed. It is likely that the 3'X region adopts more than one structural form in infected cells and that a specific equilibrium between the various forms regulates several aspects of the viral life cycle. The most intriguing explanations of the structural heterogeneity problem of the 3'X region came with the discovery of its involvement in long-range RNA-RNA interactions and the potential for homodimer formation. This article summarizes current knowledge on the structure and function of the 3'X region of hepatitis C genomic RNA, reviews previous opinions, presents new hypotheses and summarizes the questions that still remain unanswered.
Keywords: 3’UTR; 3’X RNA; 3’X region; 3’X-tail; Hepatitis C virus; RNA structure.
Conflict of interest statement
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Figures
References
-
- Choo KB, Liew LN, Wang HC. Production of transgenic mice carrying the human hepatitis B virus or the human papillomavirus DNA sequences in Taiwan: analysis of physical structure and hereditary mode. Proc Natl Sci Counc Repub China B. 1989;13:314–318. - PubMed
-
- Bartenshlager R. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Current Topics in Microbiology and Immunology. 2013;369:V–VI.
-
- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–1342. - PubMed
-
- Dev A, Patel K, McHutchison JG. New therapies for chronic hepatitis C virus infection. Curr Gastroenterol Rep. 2004;6:77–86. - PubMed
-
- Rijnbrand RC, Lemon SM. Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol. 2000;242:85–116. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
